VEGFA and triple-A syndrome: In animal models of AAA, administration of exogenous VEGF-A was previously found to augment AAA formation, while the reduction of VEGF-A signaling by soluble receptors or inhibitors (e.g., kallistatin) caused inhibition of AAA development [61,62,63,64].